The landscape of psychiatric medicine is undergoing a profound transformation as pharmaceutical companies transition from chronic, daily-dosing regimens to high-intensity,…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a radical structural transformation driven by the collision of two opposing…
Read More
TWiV 1284: Clinical Update with Dr. Daniel Griffin and Vincent Racaniello Focuses on Resurgent Infectious Diseases and Evidence-Based Practice
The landscape of public health in the United States faces a complex array of challenges as the medical community navigates…
Read More
TWiV 1286: Clinical update with Dr. Daniel Griffin
The landscape of public health policy and infectious disease management faces a critical juncture, characterized by intense friction between established…
Read More
FDA Approves Eli Lilly’s Once-Weekly Basal Insulin Onswik for Type 2 Diabetes Following Robust Phase III Clinical Trials
The United States Food and Drug Administration has officially granted marketing authorization to Eli Lilly and Company for Onswik, chemically…
Read More
Beyond the Statistics: Reevaluating Safety Metrics in the Modern Clinical Laboratory
Every year, the Bureau of Labor Statistics releases its comprehensive summary of workplace injuries and illnesses, and every year, the…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
Public health infrastructure and evidence-based medicine face mounting tension as scientific communities respond to proposed alterations in national health policy.…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In the latest installment of their weekly clinical update series, Dr. Daniel Griffin and virologist Vincent Racaniello have released episode…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin | Microbe TV
The landscape of public health in the United States faces unprecedented challenges, marked by systemic policy shifts, institutional withdrawals, and…
Read More
Navigating the Oncology Enrollment Funnel: Why Cancer Clinical Trials Face Protracted Timelines and High Screen Failures
The modern landscape of oncology drug development is characterized by profound scientific breakthroughs, yet it remains perpetually bottlenecked by an…
Read More
